First GCC stakeholder meeting on approval process, interchangeability/substitution and safety of biosimilars 2017 – Report

Pub Date : 2018-12-15 DOI:10.5639/gabij.2018.0704.032
Gianluca Trifi rò, Meteb Al-Foheidi, Ali M Alhomaidan, A. Al-jedai, Musaed Alkholief, Mohammad Alsenaidy, A. Alshamsan, T. Kvien
{"title":"First GCC stakeholder meeting on approval process, interchangeability/substitution and safety of biosimilars 2017 – Report","authors":"Gianluca Trifi rò, Meteb Al-Foheidi, Ali M Alhomaidan, A. Al-jedai, Musaed Alkholief, Mohammad Alsenaidy, A. Alshamsan, T. Kvien","doi":"10.5639/gabij.2018.0704.032","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5639/gabij.2018.0704.032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
分享
查看原文
首次GCC利益相关方会议,讨论2017年生物仿制药的批准流程、可互换性/替代性和安全性
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信